Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry Bresnihan

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Arthritis and Rheumatism|July 27, 2006
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J Haringman, Danielle M Gerlag, Tom J M Smeets, et al.
Annals of the Rheumatic Diseases|August 10, 2010
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trialArno W R van Kuijk, Clarissa E Vergunst, Danielle M Gerlag, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
The Journal of Rheumatology|March 9, 2007
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schemaMarissa N Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis Research & Therapy|January 16, 2009
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA studyTuulikki Sokka, Sergio Toloza, Maurizio Cutolo, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Arthritis and Rheumatism|July 27, 2006
A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritisJasper J Haringman, Danielle M Gerlag, Tom J M Smeets, et al.
Annals of the Rheumatic Diseases|August 10, 2010
CCR5 blockade in rheumatoid arthritis: a randomised, double-blind, placebo-controlled clinical trialArno W R van Kuijk, Clarissa E Vergunst, Danielle M Gerlag, et al.
Annals of the Rheumatic Diseases|April 7, 2007
QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countriesTuulikki Sokka, Hannu Kautiainen, Sergio Toloza, et al.
The Journal of Rheumatology|March 9, 2007
Definitions and validation criteria for biomarkers and surrogate endpoints: development and testing of a quantitative hierarchical levels of evidence schemaMarissa N Lassere, Kent R Johnson, Maarten Boers, et al.
Arthritis Research & Therapy|January 16, 2009
Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA studyTuulikki Sokka, Sergio Toloza, Maurizio Cutolo, et al.
Pageof 7